Presentations and Corporate Materials
January 18, 2022
October 14, 2020
October 14, 2020
October 14, 2020
October 14, 2020
August 6, 2020
January 10, 2020
December 4, 2018
December 6, 2017
May 18, 2017
Video Library
Show All
Revance Announces Top-Line Results for ASPEN-1
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA.
Learn More About Cervical Dystonia with Dr. Joseph Jankovic
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA.
Announcing SAKURA 3 Results
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA. Anticipated approval in 2020.
Dr. Jean Carruthers and Dr. Shannon Humphrey on SAKURA 3 Results
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA. Anticipated approval in 2020.
Dr. Sabrina Fabi on SAKURA 3 Results
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA. Anticipated approval in 2020.
